Serina Therapeutics
About:
Serina Therapeutics employs its proprietary polymer technology to develop treatments for cancer, inflammation, pain and metabolic disorders.
Website: http://www.serinatherapeutics.com
Top Investors: Innovate Alabama
Description:
Serina Therapeutics is a privately-held pharmaceutical company that is advancing novel therapeutics for cancer, inflammation, pain, and metabolic disorders using its proprietary polymer technology. They have created new pharmaceutical candidates using polyoxazoline (POZ), a safe, water-soluble polymer to which they can attach a variety of small molecules, proteins, peptides, and DNA. The attachment of these molecules to polymers of POZ typically confers a unique pharmacokinetic profile that is markedly different from the parent compound, and this profile may confer advantages in terms of safety and efficacy.
$35.7M
$1M to $10M
Huntsville, Alabama, United States
2007-01-01
info(AT)serinatherapeutics.com
Michael Bentley
1-10
2022-08-30
Public
© 2025 bioDAO.ai